THEURAN INAHJA VICENTE MACHADO

Índice h a partir de 2011
2
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina

Filtros

Limpar filtros

Configurações

Resultados de Busca

Agora exibindo 1 - 2 de 2
  • article 12 Citação(ões) na Scopus
    Atrial Fibrillation and Cancer
    (2021) HAJJAR, Ludhmila Abrahao; FONSECA, Silvia Moulin Ribeiro; MACHADO, Theuran Inahja Vicente
    Cancer patients have a higher risk of atrial fibrillation (AF) than general population, the pathophysiology mechanisms involves the pro inflammatory status of immune system in these patients and the exacerbated inflammatory response to cancer treatment and surgeries. Adequate management and prophylaxis for its occurrence are important and reduce morbidity and mortality in this population. There is a challenge in AF related to cancer to predict thromboembolic and bleeding risk in these patients, once standard stroke and hemorrhagic prediction scores are not validated for them. It is used CHA2DS2-VASc and HAS-BLED scores, the same as used in general population. In this review, we demonstrate correlated mechanisms to occurrence AF in cancer patients as well as therapeutic challenges in this population.
  • article 57 Citação(ões) na Scopus
    The Heart and COVID-19: What Cardiologists Need to Know
    (2020) COSTA, Isabela Bispo Santos da Silva; BITTAR, Cristina Salvadori; RIZK, Stephanie Itala; ARAUJO FILHO, Antonio Everaldo de; SANTOS, Karen Alcantara Queiroz; MACHADO, Theuran Inahja Vicente; ANDRADE, Fernanda Thereza de Almeida; GONZALEZ, Thalita Barbosa; AREVALO, Andrea Nataly Galarza; ALMEIDA, Juliano Pinheiro de; BACAL, Fernando; OLIVEIRA, Glaucia Maria Moraes de; LACERDA, Marcus Vinicius Guimaraes de; BARBERATO, Silvio Henrique; CHAGAS, Antonio Carlos Palandri; ROCHITTE, Carlos Eduardo; RAMIRES, Jose Antonio Franchini; KALIL FILHO, Roberto; HAJJAR, Ludhmila Abrahao
    In face of the pandemic of the novel coronavirus disease 2019 (COVID-19), the management of patients with cardiovascular risk factors and/or disease is challenging. The cardiovascular complications evidenced in patients with COVID-19 derive from several mechanisms, ranging from direct viral injury to complications secondary to the inflammatory and thrombotic responses to the infection. The proper care of patients with COVID-19 requires special attention to the cardiovascular system aimed at better outcomes.